Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-11-21
1992-12-22
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514215, 514216, 514397, 514398, A61K 3144, A61K 3155, A61K 31415
Patent
active
051734940
ABSTRACT:
4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine derivatives such as 1-(4-amino-3-methylphenyl) methyl-5-diphenylacetyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-car boxylic acid are useful for treatment of CNS disorders, such as cognitive and learning disorders, mediated by angiotensin-II.
REFERENCES:
patent: 4301169 (1981-11-01), Yamanaka et al.
patent: 4402966 (1983-09-01), Yamanaka et al.
patent: 4533669 (1985-08-01), Yamanaka et al.
patent: 4602031 (1986-07-01), Yamanaka et al.
patent: 4812462 (1989-03-01), Blankley et al.
Mann. Exp. Brain Res.. vol. 4, suppl. pp. 242, 1982.
Fitzsimons, Rev. Physiol. Biochem. Pharmacol., vol. 87, pp. 117, 1980.
Scholken et al., Experientia., vol. 38, pp. 469, 1982.
Koller, et al., Neuroscience Lett., vol. 14, pp. 71-75, 1975.
Morgan and Routtengerg, Science, vol. 196, pp. 87-89, 1977.
Arregui, et al., J. Neurochem, vol. 38, pp. 1490-1692, 1982.
Zubenko, et al., Biol. Psych., vol. 21, pp. 1365-1381, 1986.
Usinger, et al., Drug Dev. Research, vol. 14, pp. 315-324, 1988.
Costall, et al., Pharmacol. Biochem. Behav., vol. 33, pp. 573-579, 1989.
Barnes et al., Brain Research, vol. 491, pp. 136-143, 1989.
Chiu, et al., Biochem. and Biophys. Res. Comm., vol. 165, pp. 196-203, 1989.
Whitebread, et al., Biochem and Biophys. Res. Comm., vol. 163, pp. 284-291, 1989.
Bennet and Snyder, J. Biol. Chem., vol. 254, pp. 7423-7430, 1976.
Unger et al., Circulation, vol. 77 (suppl. I) pp. 40-54, 1988.
Chiu Andrew T.
Duncia John J.
Criares T. J.
E. I. Du Pont de Nemours and Company
Waddell Frederick E.
LandOfFree
Specific inhibition of angiotensin-II binding to angiotensin-II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific inhibition of angiotensin-II binding to angiotensin-II , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific inhibition of angiotensin-II binding to angiotensin-II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-975486